UBS Raises the Price Target on HCA Holdings (HCA) Following a Quarter Preview
UBS reiterates a Buy rating on HCA Holdings (NYSE: HCA), and raises the price target to $106.00 (from $99.00), following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
